Iranian researchers of Tehran University of Medical Sciences studied and produced a Nano drug system at laboratorial scale to achieve edible insulin.
Author of the study Kobra Omidfar said that the nono-drug increases the diffusivity of insulin to intestinal wall and decreases degradation against enzymes. Biocompatible and non-toxic nanoparticles have been used in the production of the nano-drug, the Iranian students' news agency reported.
The researchers released a covered nanoparticle vesicles synthesized with trimethyl chitosan and investigated its capability for insulin transfer in laboratory.
The results showed that the medical nano-drug prevents insulin destruction and improves permeability of insulin large molecules into monolayer cells of the intestinal wall.
The nano-carrier delays insulin release and boosts its permeability into intestinal wall.
GMT 11:00 2018 Tuesday ,20 November
Iraqi children continue to suffer conflict, inequality in last 7 yearsGMT 18:15 2018 Wednesday ,05 September
Shaikh Khalid bin Hamad receives Bahraini researcherGMT 22:05 2018 Monday ,15 January
DERASAT ranked among top five Arab research centresGMT 04:26 2018 Tuesday ,09 January
IES honored with Meritorious AIP Best Performing School Award 2017GMT 22:21 2018 Monday ,01 January
Works minister receives researcherGMT 00:07 2017 Tuesday ,26 December
Study on thermal insulation presentedGMT 10:31 2017 Wednesday ,20 December
‘Turkish Corner’ to help students, researchers understand Turkish cultureGMT 08:35 2017 Sunday ,19 November
AGU showcases international research in medical computer simulationMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor